Mode
Text Size
Log in / Sign up
N/A N=36 Randomized Triple-blind Treatment

Enhancing Plasticity in Stroke Patients With Severe Motor Deficit

Stroke · Cerebrovascular Accident

Enrolled (actual)
36
Serious AEs
0.0%
Results posted
Aug 2017
Primary outcome: Primary: Change in Fugl Meyer Assessment Motor Score — 7.4; 3.4; 7.2; 2.8 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
S88 Dual Output Stimulator by Grass Technologies (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Lumy Sawaki
Primary completion
Dec 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Fugl Meyer Assessment Motor Score
7.4; 3.4; 7.2; 2.8
SECONDARY
Change in Action Arm Research Test (ARAT)
6.4; 2.3; 6.9; 2.4
SECONDARY
Change in Wolf Motor Function Test (WMFT)
-0.18; -0.06; -0.14; -0.07

Summary

This study will evaluate the effectiveness of sustained peripheral nerve stimulation coupled with functional motor training, to improve hand motor function in poorly recovered stroke patients. The central hypothesis is that stroke patients with severe motor deficit receiving hand nerve stimulation and intensive task-oriented therapy will have improved motor function compared to patients receiving sham nerve stimulation and task-oriented therapy.

Eligibility Criteria

Inclusion Criteria

  • Chronic stroke patients
  • Single stroke
  • Chronic (more than 12 months after from stroke)
  • At least 21 years old, but there is no upper age range for this project.
  • Participants NOT able to extend the affected metacarpophalangeal joints at least 10° and the wrist 20°.

Exclusion Criteria

  • History of carpal tunnel syndrome and conditions that commonly cause peripheral neuropathy, including diabetes, uremia, or associated nutritional deficiencies
  • History of head injury with loss of consciousness, severe alcohol or drug abuse, psychiatric illness
  • Within 3 months of recruitment, use of drugs known to exert detrimental effects on motor recovery
  • Cognitive deficit severe enough to preclude informed consent
  • Positive pregnancy test or being of childbearing age and not using appropriate contraception
  • Participants with history of untreated depression.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02633215). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search